During the past decade, Millenia Psychiatry & Research, Inc conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Millenia Psychiatry & Research, Inc" are "Depressive Disorder, Major" (3 trials), "Major Depressive Disorder" (2 trials) and "Treatment Resistant Depression" (1 trials). Many other conditions were trialed in "Millenia Psychiatry & Research, Inc" in a lesser frequency.

Most popular intervention types in "Millenia Psychiatry & Research, Inc" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rapastinel" (3 trials), "Placebo" (2 trials), "DVS SR" (1 trials), "Desvenlafaxine Succinate Sustained-Release" (1 trials) and "Placebo-matching Rapastinel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Millenia Psychiatry & Research, Inc" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Millenia Psychiatry & Research, Inc". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Millenia Psychiatry & Research, Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Millenia Psychiatry & Research, Inc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".